Gram-negative bacterial bloodstream infections in cancer patients: a study of epidemiological trends and antibiotic susceptibility

Author: admin
Published date: 21 October 2025
Category:
Surveillance
Share

A study from Ankara Bilkent City Hospital (2019–2023) examined 569 Gram-negative bloodstream infections (BSIs) in 435 cancer and hematology patients. The most common pathogens were E. coli (40.6%), Klebsiella spp. (28.8%), and Pseudomonas spp. (9.1%). Alarmingly, 47.7% of isolates were multidrug-resistant (MDR) and 26.7% produced extended-spectrum beta-lactamase (ESBL).

Resistance levels were particularly high for Klebsiella spp. (56.1% MDR; 27.4% carbapenem-resistant) and Acinetobacter spp. (56.5% MDR; 52.2% carbapenem-resistant). Meropenem susceptibility remained relatively high for E. coli (93.4%) but was notably lower for Klebsiella (79.1%) and Pseudomonas (72.9%).

The findings reveal a worrying burden of MDR and carbapenem-resistant Gram-negative infections in immunocompromised cancer patients, emphasizing the urgent need for stronger antimicrobial stewardship, revised treatment guidelines, and novel therapeutic options.

Stay Updated

Stay connected to keep up with the latest on antimicrobial resistance.

Name(Required)